New drug might offer longer lives to people with Marfan syndrome

03/25/2008 | BBC

People with Marfan syndrome, a rare genetic disorder, often suffer from excessive growth, eyesight problems and a frail cardiovascular system. But clinical trials of a new heart drug, Losartan, are offering new hope. "Every year, many people die unnecessarily as a result of Marfans," said geneticist Paul Brennan, who runs a Marfan syndrome clinic.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Senior Researcher (8194)
American Institute for Researcher
Washington, DC
Technical Assistance Consultant (8336)
Chicago, IL
Senior ELL Technical Assistance and Curriculum Specialist (8270)
American Institute for Researcher
Chicago, IL
Technical Assistance Associate (8330)
American Institute for Researcher
Chicago, IL
Vice Principal of Academics
Presentation High School
San Jose, CA